🇺🇸 First line chemotherapy in United States
2 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 2
Most-reported reactions
- Drug Resistance — 1 report (50%)
- Malignant Neoplasm Progression — 1 report (50%)
Frequently asked questions
Is First line chemotherapy approved in United States?
First line chemotherapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for First line chemotherapy in United States?
Hoffmann-La Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.